MOBILE Health Intervention in IntraCerebral Hemorrhage Survivors
Recruiting · NCT05830305 · Interventional (participants receive a specific treatment) · Lead sponsor: The University of Hong Kong
View the official record on ClinicalTrials.gov →Interventions studied
Mobile health intervention
What this trial is about
This randomized controlled trial investigates the efficacy and safety of mobile health intervention in managing hypertension after Intracerebral Hemorrhage (ICH).
Who can take part
Age range
18 Years to 85 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Primary ICH Diagnosis
- Age ≥ 18 years
- Discharge Modified Rankin Scale of ≤4
Exclusion criteria
- Expected life expectancy of \<1 year
- Patient or caregiver does not have access to WeRISE App.
- Patient or caregiver does not know how to use WeRISE App .
- Inability to perform home BP monitoring
- Inability to participate in follow-up activity
- Contraindication for intensive and rapid lowering of blood pressure (Known \>70% cerebral vascular stenosis; History of fall, dizziness or syncope due to hypotension; Any other medical condition that is deemed contraindicated for low blood pressure
- Bleeding tendency (Platelet count \< 75 x 10\^9/L; Known coagulation disorder)
- Severe renal impairment (Estimated glomerular filtration rate using CKD-EPI formula \<30 ml/min/1.73m2)
- Severe liver impairment (Child-Pugh C cirrhosis)
- Known contraindication or allergy to two or more anti-hypertensive classes
Where it is running
1 location listed.
- Queen Mary Hospital - Hong Kong, Hong Kong